Boston Scientific Corporation (BSX - Free Report) was a big mover last session, as the company saw its shares rise more than 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. The stock picked up sharply from the near-flat trend of $24.79 to $25.97 in the past one month time frame.
The move came after the company announced its preliminary unaudited sales of roughly $2.41 billion for the fourth quarter ended Dec 31, 2017, representing roughly 9.9% growth on reported basis.
The company has seen a mixed track record when it comes to estimate revision of one increase and three decreases over the past few months, while the Zacks Consensus Estimate for the current quarter remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Boston Scientific currently has a Zacks Rank #4 (Sell) while its Earnings ESP is positive.
Investors interested in the Medical – Products industry may consider Bio-Rad Laboratories, Inc. (BIO - Free Report) , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is BSX going up? Or down? Predict to see what others think:Up or Down
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>